Provided by Tiger Trade Technology Pte. Ltd.

Intellia Therapeutics

12.84
+0.40003.22%
Post-market: 13.020.1800+1.40%19:50 EDT
Volume:3.35M
Turnover:43.22M
Market Cap:1.80B
PE:-3.84
High:13.13
Open:12.65
Low:12.65
Close:12.44
52wk High:28.25
52wk Low:7.95
Shares:140.00M
Float Shares:137.56M
Volume Ratio:0.92
T/O Rate:2.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3456
EPS(LYR):-3.8100
ROE:-55.44%
ROA:-30.14%
PB:2.47
PE(LYR):-3.37

Loading ...

Intellia Therapeutics price target lowered to $49 from $58 at Canaccord

TIPRANKS
·
May 12

Intellia Therapeutics reports Q1 EPS (81c), consensus (90c)

TIPRANKS
·
May 12

Myles Minter Reiterates Buy on Intellia (NTLA), Citing Extended Cash Runway and Strong Phase III Data for Lonvoguran Ziclumeran

TIPRANKS
·
May 12

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE), Intellia Therapeutics (NTLA) and Corvus Pharmaceuticals (CRVS)

TIPRANKS
·
May 11

Intellia Therapeutics Q1 Loss Narrows, Revenue Falls

MT Newswires Live
·
May 11

Intellia Therapeutics Q1 net loss narrows on lower R&D spending

Reuters
·
May 11

Intellia Therapeutics Q1 EPS $(0.81) Beats $(0.90) Estimate, Sales $15.048M Beat $14.793M Estimate

Benzinga Earnings
·
May 11

Earnings Flash (NTLA) Intellia Therapeutics Posts Q1 Net Loss $0.81 a Share, vs. FactSet Est of $0.91 Loss

MT Newswires Live
·
May 11

BRIEF-Intellia Therapeutics Q1 Net Income USD -96.231 Million

Reuters
·
May 11

Intellia Q1 FY26 net loss narrows 15.9% to $96.2 million

Reuters
·
May 11

Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates

THOMSON REUTERS
·
May 11

Intellia Therapeutics Q1 Basic EPS USD -0.81

THOMSON REUTERS
·
May 11

Is Intellia Therapeutics (NTLA) Pricing Reflect Its Gene Editing Potential After Recent Price Surge

Simply Wall St.
·
May 09

Intellia Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 05

Cathie Wood’s ARK Investment buys 141K shares of Intellia Therapeutics today

TIPRANKS
·
May 02

Intellia awards 208,850 inducement RSUs to 43 new employees under 2024 plan

Reuters
·
May 02

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 02

Intellia Therapeutics Prices Public Equity Offering to Fund Pipeline

TIPRANKS
·
May 01

Intellia Therapeutics announces annual shareholder meeting notice

Reuters
·
May 01

Stock Track | Intellia Therapeutics Soars 5.02% Intraday as Cathie Wood's ARK Investment Buys 2.4M Shares

Stock Track
·
Apr 30